| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | axon guidance receptor activity | 7.97e-06 | 13 | 62 | 3 | GO:0008046 | |
| GeneOntologyMolecularFunction | transmembrane-ephrin receptor activity | 1.26e-05 | 15 | 62 | 3 | GO:0005005 | |
| GeneOntologyMolecularFunction | ephrin receptor activity | 2.67e-05 | 19 | 62 | 3 | GO:0005003 | |
| GeneOntologyMolecularFunction | kainate selective glutamate receptor activity | 1.41e-04 | 6 | 62 | 2 | GO:0015277 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 1.41e-04 | 85 | 62 | 4 | GO:0019199 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 5.78e-04 | 465 | 62 | 7 | GO:0046873 | |
| GeneOntologyMolecularFunction | potassium channel activity | 6.74e-04 | 128 | 62 | 4 | GO:0005267 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | EPHB2 EPHB3 GIPR GPR39 TLR2 SOSTDC1 ABCC9 GRIK1 GRIK3 OSMR OR7A17 EPHB1 | 8.13e-04 | 1353 | 62 | 12 | GO:0004888 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 9.42e-04 | 140 | 62 | 4 | GO:0099094 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 1.09e-03 | 65 | 62 | 3 | GO:0004714 | |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 1.25e-03 | 17 | 62 | 2 | GO:0004970 | |
| GeneOntologyMolecularFunction | ligand-gated sodium channel activity | 1.41e-03 | 18 | 62 | 2 | GO:0015280 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 1.81e-03 | 167 | 62 | 4 | GO:0015079 | |
| GeneOntologyMolecularFunction | glucosyltransferase activity | 2.11e-03 | 22 | 62 | 2 | GO:0046527 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 2.51e-03 | 24 | 62 | 2 | GO:0099507 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 3.03e-03 | 793 | 62 | 8 | GO:0015075 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 3.05e-03 | 193 | 62 | 4 | GO:0015276 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 3.17e-03 | 27 | 62 | 2 | GO:0008066 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 3.21e-03 | 627 | 62 | 7 | GO:0022890 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 3.28e-03 | 197 | 62 | 4 | GO:0022834 | |
| GeneOntologyMolecularFunction | gated channel activity | 3.77e-03 | 334 | 62 | 5 | GO:0022836 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 4.39e-03 | 664 | 62 | 7 | GO:0008324 | |
| GeneOntologyCellularComponent | kainate selective glutamate receptor complex | 1.37e-04 | 6 | 64 | 2 | GO:0032983 | |
| GeneOntologyCellularComponent | potassium channel complex | 2.92e-04 | 104 | 64 | 4 | GO:0034705 | |
| MousePheno | abnormal axon pruning | 2.68e-06 | 8 | 52 | 3 | MP:0008960 | |
| MousePheno | increased circulating glucose level | KNTC1 GIPR IQSEC3 RAPGEF3 GPR39 GRIK3 BBS5 CEP126 OSMR CCDC51 | 3.05e-05 | 553 | 52 | 10 | MP:0005559 |
| MousePheno | aortic arch dilation | 4.06e-05 | 3 | 52 | 2 | MP:0010575 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 1.30e-05 | 14 | 63 | 3 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 1.30e-05 | 14 | 63 | 3 | PS00790 | |
| Domain | Eph_TM | 1.30e-05 | 14 | 63 | 3 | IPR027936 | |
| Domain | Tyr_kinase_rcpt_V_CS | 1.30e-05 | 14 | 63 | 3 | IPR001426 | |
| Domain | EPH_lbd | 1.30e-05 | 14 | 63 | 3 | SM00615 | |
| Domain | Ephrin_lbd | 1.30e-05 | 14 | 63 | 3 | PF01404 | |
| Domain | EphA2_TM | 1.30e-05 | 14 | 63 | 3 | PF14575 | |
| Domain | Tyr_kinase_ephrin_rcpt | 1.30e-05 | 14 | 63 | 3 | IPR016257 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 1.30e-05 | 14 | 63 | 3 | IPR001090 | |
| Domain | EPH_LBD | 1.30e-05 | 14 | 63 | 3 | PS51550 | |
| Domain | Ras_G-nucl-exch_fac_CS | 1.30e-05 | 14 | 63 | 3 | IPR019804 | |
| Domain | fn3 | 1.75e-05 | 162 | 63 | 6 | PF00041 | |
| Domain | FN3 | 3.70e-05 | 185 | 63 | 6 | SM00060 | |
| Domain | RasGEFN | 4.00e-05 | 20 | 63 | 3 | SM00229 | |
| Domain | SAM/pointed | 4.66e-05 | 117 | 63 | 5 | IPR013761 | |
| Domain | RasGEF_N | 4.66e-05 | 21 | 63 | 3 | PF00618 | |
| Domain | Ras-like_Gua-exchang_fac_N | 5.38e-05 | 22 | 63 | 3 | IPR000651 | |
| Domain | RASGEF_NTER | 5.38e-05 | 22 | 63 | 3 | PS50212 | |
| Domain | FN3 | 5.56e-05 | 199 | 63 | 6 | PS50853 | |
| Domain | FN3_dom | 7.30e-05 | 209 | 63 | 6 | IPR003961 | |
| Domain | Ephrin_rec_like | 7.98e-05 | 25 | 63 | 3 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 7.98e-05 | 25 | 63 | 3 | IPR011641 | |
| Domain | SAM_1 | 8.14e-05 | 68 | 63 | 4 | PF00536 | |
| Domain | RASGEF | 9.00e-05 | 26 | 63 | 3 | PS00720 | |
| Domain | - | 1.07e-04 | 73 | 63 | 4 | 2.60.120.260 | |
| Domain | RASGEF_CAT | 1.26e-04 | 29 | 63 | 3 | PS50009 | |
| Domain | RasGEF | 1.39e-04 | 30 | 63 | 3 | PF00617 | |
| Domain | - | 1.39e-04 | 30 | 63 | 3 | 1.10.840.10 | |
| Domain | Ras_GEF_dom | 1.39e-04 | 30 | 63 | 3 | IPR023578 | |
| Domain | RASGEF_cat_dom | 1.39e-04 | 30 | 63 | 3 | IPR001895 | |
| Domain | RasGEF | 1.39e-04 | 30 | 63 | 3 | SM00147 | |
| Domain | SAM | 2.22e-04 | 88 | 63 | 4 | SM00454 | |
| Domain | Galactose-bd-like | 2.86e-04 | 94 | 63 | 4 | IPR008979 | |
| Domain | SAM_DOMAIN | 2.97e-04 | 95 | 63 | 4 | PS50105 | |
| Domain | SAM | 3.22e-04 | 97 | 63 | 4 | IPR001660 | |
| Domain | - | 4.51e-04 | 106 | 63 | 4 | 1.10.150.50 | |
| Domain | Ephrin_rec_like | 6.04e-04 | 11 | 63 | 2 | PF07699 | |
| Domain | Iontro_rcpt | 1.65e-03 | 18 | 63 | 2 | IPR001320 | |
| Domain | Lig_chan-Glu_bd | 1.65e-03 | 18 | 63 | 2 | PF10613 | |
| Domain | Iono_rcpt_met | 1.65e-03 | 18 | 63 | 2 | IPR001508 | |
| Domain | Glu/Gly-bd | 1.65e-03 | 18 | 63 | 2 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 1.65e-03 | 18 | 63 | 2 | SM00918 | |
| Domain | Lig_chan | 1.65e-03 | 18 | 63 | 2 | PF00060 | |
| Domain | PBPe | 1.65e-03 | 18 | 63 | 2 | SM00079 | |
| Domain | - | 1.67e-03 | 663 | 63 | 8 | 2.60.40.10 | |
| Domain | Growth_fac_rcpt_ | 1.90e-03 | 156 | 63 | 4 | IPR009030 | |
| Domain | Ig-like_fold | 2.47e-03 | 706 | 63 | 8 | IPR013783 | |
| Domain | TyrKc | 3.27e-03 | 88 | 63 | 3 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 3.27e-03 | 88 | 63 | 3 | IPR020635 | |
| Pathway | REACTOME_EPHRIN_SIGNALING | 2.92e-05 | 18 | 48 | 3 | MM15024 | |
| Pathway | REACTOME_EPHRIN_SIGNALING | 3.46e-05 | 19 | 48 | 3 | M27310 | |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 2.06e-04 | 34 | 48 | 3 | MM15025 | |
| Pathway | REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING | 2.65e-04 | 37 | 48 | 3 | MM15022 | |
| Pathway | WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT | 3.35e-04 | 40 | 48 | 3 | M39798 | |
| Pathway | PID_EPHB_FWD_PATHWAY | 3.35e-04 | 40 | 48 | 3 | M62 | |
| Pathway | REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING | 3.87e-04 | 42 | 48 | 3 | M27308 | |
| Pathway | WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER | 4.16e-04 | 43 | 48 | 3 | M39788 | |
| Pathway | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | 5.02e-04 | 10 | 48 | 2 | M10272 | |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 6.88e-04 | 51 | 48 | 3 | M27311 | |
| Pathway | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | 7.33e-04 | 12 | 48 | 2 | MM15142 | |
| Pubmed | EphB regulates L1 phosphorylation during retinocollicular mapping. | 3.63e-10 | 7 | 64 | 4 | 22579729 | |
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 25051176 | ||
| Pubmed | Multiple EphB receptor tyrosine kinases shape dendritic spines in the hippocampus. | 5.94e-09 | 3 | 64 | 3 | 14691139 | |
| Pubmed | A chemical genetic approach reveals distinct EphB signaling mechanisms during brain development. | 5.94e-09 | 3 | 64 | 3 | 23143520 | |
| Pubmed | EphB receptors couple dendritic filopodia motility to synapse formation. | 5.94e-09 | 3 | 64 | 3 | 18614029 | |
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 29731254 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 35025117 | ||
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 22622783 | ||
| Pubmed | Retinal axon growth cones respond to EphB extracellular domains as inhibitory axon guidance cues. | 5.94e-09 | 3 | 64 | 3 | 11532925 | |
| Pubmed | EphB2 receptor forward signaling controls cortical growth cone collapse via Nck and Pak. | 2.37e-08 | 4 | 64 | 3 | 23147113 | |
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 22475621 | ||
| Pubmed | Eph receptor deficiencies lead to altered cochlear function. | 2.37e-08 | 4 | 64 | 3 | 12684184 | |
| Pubmed | GRIP1 controls dendrite morphogenesis by regulating EphB receptor trafficking. | 2.37e-08 | 4 | 64 | 3 | 15965473 | |
| Pubmed | Role for ephrinB2 in postnatal lung alveolar development and elastic matrix integrity. | 3.13e-08 | 18 | 64 | 4 | 18651661 | |
| Pubmed | Critical roles for EphB and ephrin-B bidirectional signalling in retinocollicular mapping. | 5.93e-08 | 5 | 64 | 3 | 21847105 | |
| Pubmed | Eph receptors are involved in the activity-dependent synaptic wiring in the mouse cerebellar cortex. | 5.93e-08 | 5 | 64 | 3 | 21559471 | |
| Pubmed | 1.18e-07 | 6 | 64 | 3 | 26148571 | ||
| Pubmed | Distribution of EphB receptors and ephrin-B1 in the developing vertebrate spinal cord. | 1.18e-07 | 6 | 64 | 3 | 16786562 | |
| Pubmed | Ephrin-B3 reverse signaling through Grb4 and cytoskeletal regulators mediates axon pruning. | 1.18e-07 | 6 | 64 | 3 | 19182796 | |
| Pubmed | Abnormal hippocampal axon bundling in EphB receptor mutant mice. | 1.18e-07 | 6 | 64 | 3 | 15014111 | |
| Pubmed | 2.07e-07 | 7 | 64 | 3 | 8954633 | ||
| Pubmed | 2.07e-07 | 7 | 64 | 3 | 22103419 | ||
| Pubmed | 3.31e-07 | 8 | 64 | 3 | 17884558 | ||
| Pubmed | 4.95e-07 | 9 | 64 | 3 | 10704386 | ||
| Pubmed | 4.95e-07 | 9 | 64 | 3 | 11403717 | ||
| Pubmed | 4.95e-07 | 9 | 64 | 3 | 18713744 | ||
| Pubmed | 4.95e-07 | 9 | 64 | 3 | 33253166 | ||
| Pubmed | 4.95e-07 | 9 | 64 | 3 | 11580899 | ||
| Pubmed | 4.95e-07 | 9 | 64 | 3 | 10683176 | ||
| Pubmed | 7.07e-07 | 10 | 64 | 3 | 32092051 | ||
| Pubmed | EphB signaling regulates target innervation in the developing and deafferented auditory brainstem. | 7.07e-07 | 10 | 64 | 3 | 22021100 | |
| Pubmed | 7.07e-07 | 10 | 64 | 3 | 25923646 | ||
| Pubmed | EphB2 guides axons at the midline and is necessary for normal vestibular function. | 7.07e-07 | 10 | 64 | 3 | 10839360 | |
| Pubmed | 9.70e-07 | 11 | 64 | 3 | 22171039 | ||
| Pubmed | Ephrin-B1 regulates axon guidance by reverse signaling through a PDZ-dependent mechanism. | 9.70e-07 | 11 | 64 | 3 | 19515977 | |
| Pubmed | Ephrin/ephrin receptor expression during early stages of mouse inner ear development. | 1.29e-06 | 12 | 64 | 3 | 21465626 | |
| Pubmed | Retrograde regulation of mossy fiber axon targeting and terminal maturation via postsynaptic Lnx1. | 1.68e-06 | 13 | 64 | 3 | 30185604 | |
| Pubmed | EphB-ephrin-B2 interactions are required for thymus migration during organogenesis. | 1.68e-06 | 13 | 64 | 3 | 20616004 | |
| Pubmed | 1.68e-06 | 13 | 64 | 3 | 16421308 | ||
| Pubmed | Eph/Ephrin Signaling Controls Progenitor Identities In The Ventral Spinal Cord. | 2.66e-06 | 15 | 64 | 3 | 28595615 | |
| Pubmed | Proper closure of the optic fissure requires ephrin A5-EphB2-JNK signaling. | 2.66e-06 | 15 | 64 | 3 | 26839344 | |
| Pubmed | 3.27e-06 | 16 | 64 | 3 | 19109910 | ||
| Pubmed | Nolz1 expression is required in dopaminergic axon guidance and striatal innervation. | 3.31e-06 | 55 | 64 | 4 | 32561725 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 19320626 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 29727015 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 31633063 | ||
| Pubmed | Cell-autonomous role of EphB2 and EphB3 receptors in the thymic epithelial cell organization. | 3.33e-06 | 2 | 64 | 2 | 19731361 | |
| Pubmed | Involvement of EphB/Ephrin-B signaling in axonal survival in mouse experimental glaucoma. | 3.33e-06 | 2 | 64 | 2 | 22064993 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 27124026 | ||
| Pubmed | EphB receptors coordinate migration and proliferation in the intestinal stem cell niche. | 3.33e-06 | 2 | 64 | 2 | 16777604 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 38558087 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 29027839 | ||
| Pubmed | Null mutations in EphB receptors decrease sharpness of frequency tuning in primary auditory cortex. | 3.33e-06 | 2 | 64 | 2 | 22022561 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 32506584 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 12165470 | ||
| Pubmed | Intracellular and trans-synaptic regulation of glutamatergic synaptogenesis by EphB receptors. | 3.33e-06 | 2 | 64 | 2 | 17122040 | |
| Pubmed | The Eph/ephrinB signal balance determines the pattern of T-cell maturation in the thymus. | 3.33e-06 | 2 | 64 | 2 | 21243004 | |
| Pubmed | Disruption of segmental neural crest migration and ephrin expression in delta-1 null mice. | 3.97e-06 | 17 | 64 | 3 | 12217323 | |
| Pubmed | Ephrin-B2 and EphB1 mediate retinal axon divergence at the optic chiasm. | 3.97e-06 | 17 | 64 | 3 | 12971893 | |
| Pubmed | 4.75e-06 | 18 | 64 | 3 | 16854408 | ||
| Pubmed | Expression of Ephs and ephrins in developing mouse inner ear. | 5.64e-06 | 19 | 64 | 3 | 12684176 | |
| Pubmed | Multiple roles of EPH receptors and ephrins in neural development. | 6.63e-06 | 20 | 64 | 3 | 11256076 | |
| Pubmed | 6.63e-06 | 20 | 64 | 3 | 10207129 | ||
| Pubmed | 6.63e-06 | 20 | 64 | 3 | 9530499 | ||
| Pubmed | 6.63e-06 | 20 | 64 | 3 | 9576626 | ||
| Pubmed | 7.72e-06 | 21 | 64 | 3 | 9267020 | ||
| Pubmed | 7.72e-06 | 21 | 64 | 3 | 11128993 | ||
| Pubmed | Eph receptors and ephrins demarcate cerebellar lobules before and during their formation. | 7.72e-06 | 21 | 64 | 3 | 10495276 | |
| Pubmed | Developmental expression of Eph and ephrin family genes in mammalian small intestine. | 7.72e-06 | 21 | 64 | 3 | 20112066 | |
| Pubmed | Eph receptors and ephrins: regulators of guidance and assembly. | 7.72e-06 | 21 | 64 | 3 | 10730216 | |
| Pubmed | Genetic analysis of the role of Eph receptors in the development of the mammalian nervous system. | 9.99e-06 | 3 | 64 | 2 | 9321682 | |
| Pubmed | EphB receptor activity suppresses colorectal cancer progression. | 9.99e-06 | 3 | 64 | 2 | 15973414 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 9499402 | ||
| Pubmed | Completing the structural family portrait of the human EphB tyrosine kinase domains. | 9.99e-06 | 3 | 64 | 2 | 24677421 | |
| Pubmed | Kinase-independent requirement of EphB2 receptors in hippocampal synaptic plasticity. | 9.99e-06 | 3 | 64 | 2 | 11754835 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 20660266 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 31513786 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 27810913 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 18057206 | ||
| Pubmed | Bidirectional signaling mediated by ephrin-B2 and EphB2 controls urorectal development. | 9.99e-06 | 3 | 64 | 2 | 15223334 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 34296545 | ||
| Pubmed | TFCP2c/LSF/LBP-1c is required for Snail1-induced fibronectin gene expression. | 9.99e-06 | 3 | 64 | 2 | 21361876 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 33991642 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 20410461 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 22009740 | ||
| Pubmed | Kainate receptor-mediated responses in the CA1 field of wild-type and GluR6-deficient mice. | 9.99e-06 | 3 | 64 | 2 | 9880586 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 15722342 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 7538211 | ||
| Pubmed | Differential trafficking of GluR7 kainate receptor subunit splice variants. | 9.99e-06 | 3 | 64 | 2 | 15805114 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 17668899 | ||
| Pubmed | Amygdala EphB2 Signaling Regulates Glutamatergic Neuron Maturation and Innate Fear. | 9.99e-06 | 3 | 64 | 2 | 27683910 | |
| Pubmed | Genetic diversity of TLR2, TLR4, and VDR loci and pulmonary tuberculosis in Moroccan patients. | 9.99e-06 | 3 | 64 | 2 | 24727508 | |
| Pubmed | 1.03e-05 | 23 | 64 | 3 | 26027930 | ||
| Pubmed | Promotion of proliferation in the developing cerebral cortex by EphA4 forward signaling. | 1.03e-05 | 23 | 64 | 3 | 19542359 | |
| Pubmed | 1.03e-05 | 23 | 64 | 3 | 19571816 | ||
| Pubmed | Eph receptors and their ephrin ligands are expressed in developing mouse pancreas. | 1.17e-05 | 24 | 64 | 3 | 16446123 | |
| Pubmed | Ca2+ homeostasis maintained by TMCO1 underlies corpus callosum development via ERK signaling. | 1.50e-05 | 26 | 64 | 3 | 35927240 | |
| Pubmed | Eph receptor interclass cooperation is required for the regulation of cell proliferation. | 2.00e-05 | 4 | 64 | 2 | 27565439 | |
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 11956217 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 15513934 | ||
| Cytoband | 1p36.3 | 1.72e-04 | 14 | 64 | 2 | 1p36.3 | |
| GeneFamily | Fibronectin type III domain containing | 2.68e-06 | 160 | 45 | 6 | 555 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 5.14e-06 | 14 | 45 | 3 | 1095 | |
| GeneFamily | Glutamate ionotropic receptor kainate type subunits | 6.03e-05 | 5 | 45 | 2 | 1199 | |
| GeneFamily | Sterile alpha motif domain containing | 6.70e-05 | 88 | 45 | 4 | 760 | |
| Coexpression | BROWNE_HCMV_INFECTION_48HR_DN | 2.51e-06 | 482 | 64 | 9 | M12144 | |
| ToppCell | CTRL-Myeloid-Neutrophil|Myeloid / Disease state, Lineage and Cell class | 1.67e-07 | 170 | 64 | 6 | 151dabe1d240dde414c881bf4fa816c69fa1c32d | |
| ToppCell | CTRL-Myeloid-Neutrophil|CTRL / Disease state, Lineage and Cell class | 1.78e-07 | 172 | 64 | 6 | ef3a6fe3b7300959f9f71130200c7fb8741c42b0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.31e-07 | 191 | 64 | 6 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.31e-07 | 191 | 64 | 6 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.73e-07 | 195 | 64 | 6 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.73e-07 | 195 | 64 | 6 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | CF-Myeloid-Neutrophil|Myeloid / Disease state, Lineage and Cell class | 5.32e-06 | 175 | 64 | 5 | 8020c3a34f77e68e8149f87481fb1dddd2ac675e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.78e-06 | 178 | 64 | 5 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.44e-06 | 182 | 64 | 5 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | CF-Myeloid-Neutrophil|CF / Disease state, Lineage and Cell class | 6.62e-06 | 183 | 64 | 5 | da43827952e6fdee2ce94648c316182f272b321c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.79e-06 | 184 | 64 | 5 | 8fd8bd3d28d0ee6f0ef1f14e354d8eaf63a8081b | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.97e-06 | 185 | 64 | 5 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.16e-06 | 186 | 64 | 5 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | CF|World / Disease state, Lineage and Cell class | 7.35e-06 | 187 | 64 | 5 | eec4d4e4a658e3a61c05745167a1a5e3d39bb43e | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.35e-06 | 187 | 64 | 5 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | droplet-Heart-HEART-1m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.54e-06 | 188 | 64 | 5 | 921a2c9212a0f2a00fd72c594d80924f27e8b9b7 | |
| ToppCell | droplet-Heart-HEART-1m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.74e-06 | 189 | 64 | 5 | a618a1ddf5097a010c6c2c7341f3a0bd46a29c02 | |
| ToppCell | droplet-Heart-HEART-1m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.74e-06 | 189 | 64 | 5 | 4e61f9cd1c06bddb47ebf98affc0f97770e26e8c | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.94e-06 | 190 | 64 | 5 | bfbdf16d488359d7935a419c4c1823288f39c183 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.94e-06 | 190 | 64 | 5 | eb1f8bb4d903b08e50c2dc173b06c0c79d8e316e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.94e-06 | 190 | 64 | 5 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.35e-06 | 192 | 64 | 5 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.56e-06 | 193 | 64 | 5 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.56e-06 | 193 | 64 | 5 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.78e-06 | 194 | 64 | 5 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.78e-06 | 194 | 64 | 5 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.78e-06 | 194 | 64 | 5 | b30379f8dc41c86c746af9930541fbb4819d8fa0 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.23e-06 | 196 | 64 | 5 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.23e-06 | 196 | 64 | 5 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.23e-06 | 196 | 64 | 5 | a4d05d85fbafa869df19bba3881020ea433d81fb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.23e-06 | 196 | 64 | 5 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.23e-06 | 196 | 64 | 5 | 91a3c3091064f1f5a3bdc1dd5883fc24dce8ff05 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.23e-06 | 196 | 64 | 5 | e819088a74d29e958371aa851ac9c74ec55367b7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.23e-06 | 196 | 64 | 5 | 3a6c942e2907aa07b5e12dbf9019d18f7bfca507 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.23e-06 | 196 | 64 | 5 | e675d661b6494ac3a85ba7ee5bdeaa98b8bbe957 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.23e-06 | 196 | 64 | 5 | bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.46e-06 | 197 | 64 | 5 | 4cf4e9553397cd8dee883dbec24f41bec41aff99 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar-Dividing_AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.46e-06 | 197 | 64 | 5 | 49689a03ab31e53386dbe15c77c09ca3a14ebf4e | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.93e-06 | 199 | 64 | 5 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.93e-06 | 199 | 64 | 5 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 1.02e-05 | 200 | 64 | 5 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.02e-05 | 200 | 64 | 5 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.02e-05 | 200 | 64 | 5 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 4.28e-05 | 135 | 64 | 4 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | (08)_PNEC-(2)_48hpi|(08)_PNEC / shred by cell type and Timepoint | 5.22e-05 | 142 | 64 | 4 | e95d34170f5053678e0dd9793e68d93c03b05822 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.13e-05 | 148 | 64 | 4 | fd0d8386b94adb1bdc993fbb44d2d87852bfd7f0 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_ALM_Cpa6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.15e-05 | 154 | 64 | 4 | 12cbc38bc1f7231c67e1d2d5e86e95bc12e24682 | |
| ToppCell | AT1-AT2_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 7.33e-05 | 155 | 64 | 4 | 010e45ef4b505bf419ea41e4d1619521d1c78319 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Papillary_Adenocarcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 7.33e-05 | 155 | 64 | 4 | 57259549d7ad97d9f628b821417be5ddac7dbff7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.09e-05 | 159 | 64 | 4 | e812cbde59188924c6277c3feadf1a9592fa62a4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.09e-05 | 159 | 64 | 4 | 2607b562903228274fbd96168ba826782fab0b53 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.09e-05 | 159 | 64 | 4 | 24f87c666eff10c1844c900ffd7ad49fa9f80481 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.09e-05 | 159 | 64 | 4 | f7bccfeffa737f151417bf52ea45111b0957bce9 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.78e-05 | 167 | 64 | 4 | 78909f685ccd1321064eb0887caf9263e0e54879 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.00e-04 | 168 | 64 | 4 | b4bb03efb601a61465260f93896c56861c588bef | |
| ToppCell | metastatic_Brain-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 1.00e-04 | 168 | 64 | 4 | 4bf3f85aac4b335efa93d22c9ce7b153cb5ce152 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.00e-04 | 168 | 64 | 4 | 240ea32b64d86f9216785010d6b237d9adf052c9 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|Myeloid_cells / Location, Cell class and cell subclass | 1.02e-04 | 169 | 64 | 4 | dba8f5599aa21feef5b7fdfed2e3ab54748d80f7 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.02e-04 | 169 | 64 | 4 | e7470a5b060881b2a8ce2ab04b0788396aa13889 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.02e-04 | 169 | 64 | 4 | 335619507857383c3b0b507cdf05d786ed59e585 | |
| ToppCell | Influenza_Severe-Neutrophil|World / Disease group and Cell class | 1.02e-04 | 169 | 64 | 4 | 6e8e2580e19c96bcf7fa6a6d8c183df65f428396 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-04 | 175 | 64 | 4 | dbd9dac129fb6ae5f55e7b96d04b37585458dc4a | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.22e-04 | 177 | 64 | 4 | 8abdf1d970b2f15e17e185f3e612dd5065c88757 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 177 | 64 | 4 | 291231b1520c135e92739e201495fe1935efa927 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 178 | 64 | 4 | ef490b45901b2e6dedb519540fa3ae4e4db3a9ba | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_macrophage-stroma-erythroid_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.28e-04 | 179 | 64 | 4 | c17ae394b855f01f8ca1765c416fd8b34a96e60b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.28e-04 | 179 | 64 | 4 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 179 | 64 | 4 | dd94ebe69ade6f51b94058abe066216f0de9feda | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.31e-04 | 180 | 64 | 4 | 1e819c5c87704ec6535dfeaae56561895e239d07 | |
| ToppCell | facs-Pancreas-Exocrine-24m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 180 | 64 | 4 | 72310baeed848f2c483ae986cd73d2fb2cca7feb | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.33e-04 | 181 | 64 | 4 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | COPD-Epithelial-Basal|World / Disease state, Lineage and Cell class | 1.33e-04 | 181 | 64 | 4 | 6d8a886b4afe729f8a05b9c0f4ea9375de735da4 | |
| ToppCell | RA-07._Pericyte|World / Chamber and Cluster_Paper | 1.36e-04 | 182 | 64 | 4 | 2075efeae633550fb2eb026d0dfd741c8252482e | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.36e-04 | 182 | 64 | 4 | e9fcae9d03a6faf85b91882c5da699037bc61aeb | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.36e-04 | 182 | 64 | 4 | d486b0213bd3cf20965cb4e38e95981c4aaff259 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.36e-04 | 182 | 64 | 4 | a1c0e4090a9e7aa4941a40c817d178de144888b6 | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 1.39e-04 | 183 | 64 | 4 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-04 | 183 | 64 | 4 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 1.39e-04 | 183 | 64 | 4 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.39e-04 | 183 | 64 | 4 | b4f29dd3994009bb5eb769d36d95886664e7f87d | |
| ToppCell | LV-07._Pericyte|World / Chamber and Cluster_Paper | 1.39e-04 | 183 | 64 | 4 | 273db6a3b00a93ca852498471187b642b5368185 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 183 | 64 | 4 | 824ecda1219fb596a01bf5cfeee29a6daa462098 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 183 | 64 | 4 | 82b84ee065fb573688d59da97a327152a1ba294c | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 183 | 64 | 4 | 8330c39184ce076e1f95fd3725b68af551d89db0 | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.42e-04 | 184 | 64 | 4 | 01257e5c12e38b849fd3d9496c43ded666249ba5 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.42e-04 | 184 | 64 | 4 | e33e2a887aafba7b6a31f00bb0dbe974b4359fd6 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.42e-04 | 184 | 64 | 4 | d754c3de621429b220ae4ac426cdfc619e848462 | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 185 | 64 | 4 | 8433a337625ff8398520e223ef92bf9bb0beb14c | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 185 | 64 | 4 | 049d793d043d5d434f143025de49dd210d18756c | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 185 | 64 | 4 | 63200c42565eea596f9b00728e70e544b8d50a7f | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.45e-04 | 185 | 64 | 4 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | normal-na-Lymphocytic_NK-NK_dim-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.45e-04 | 185 | 64 | 4 | b1a8a8c4d0fc7605eabc17dcb6bd9e8ab4fd578c | |
| ToppCell | LV-07._Pericyte|LV / Chamber and Cluster_Paper | 1.45e-04 | 185 | 64 | 4 | acb38eba871ec72f2a8136a33b87d33b8c85465d | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.48e-04 | 186 | 64 | 4 | c0a036096c2cb23305605b8aaf18869d6e0fb512 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.48e-04 | 186 | 64 | 4 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 186 | 64 | 4 | 8eafd4bea692f7ef33de27dd53f9d1fe67deaad8 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.48e-04 | 186 | 64 | 4 | 7def03dd856b765bd3f493288641981c4f7fd26e | |
| ToppCell | RV-07._Pericyte|RV / Chamber and Cluster_Paper | 1.48e-04 | 186 | 64 | 4 | c533b264fbe12bc35467486fc7fbde24ba968fe1 | |
| ToppCell | Control-Epithelial-ATII|World / Disease state, Lineage and Cell class | 1.48e-04 | 186 | 64 | 4 | f4b6e401e19a71beddc73d8a1e08359f7c4025cf | |
| ToppCell | droplet-Heart-HEART-1m-Neuronal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 186 | 64 | 4 | fddc6b93f98b10aaf8d4ebc142b46d8213f3129d | |
| Computational | Genes in the cancer module 80. | 2.04e-04 | 32 | 39 | 3 | MODULE_80 | |
| Computational | Genes in the cancer module 27. | 2.49e-04 | 355 | 39 | 7 | MODULE_27 | |
| Computational | Genes in the cancer module 51. | 2.90e-04 | 36 | 39 | 3 | MODULE_51 | |
| Drug | benzo(F)quinoxaline | 1.76e-06 | 9 | 64 | 3 | CID000098494 | |
| Drug | diazepam | 1.52e-05 | 189 | 64 | 6 | CID000003016 | |
| Drug | Trimethoprim [738-70-5]; Up 200; 13.8uM; PC3; HT_HG-U133A | 1.81e-05 | 195 | 64 | 6 | 7377_UP | |
| Drug | Dydrogesterone [152-62-5]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 1.98e-05 | 198 | 64 | 6 | 2811_UP | |
| Drug | Labetalol hydrochloride [32780-64-6]; Up 200; 11uM; MCF7; HT_HG-U133A | 2.09e-05 | 200 | 64 | 6 | 3167_UP | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 6.95e-05 | 200 | 63 | 5 | EFO_0004611, EFO_0020945 | |
| Disease | glycosyl ceramide (d18:1/20:0, d16:1/22:0) measurement | 9.36e-05 | 7 | 63 | 2 | EFO_0800551 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 3.03e-04 | 150 | 63 | 4 | EFO_0004611, EFO_0020947 | |
| Disease | cardiovascular system disease (is_implicated_in) | 9.18e-04 | 21 | 63 | 2 | DOID:1287 (is_implicated_in) | |
| Disease | vitiligo (is_implicated_in) | 9.18e-04 | 21 | 63 | 2 | DOID:12306 (is_implicated_in) | |
| Disease | Obesity | 9.78e-04 | 205 | 63 | 4 | C0028754 | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 9.96e-04 | 206 | 63 | 4 | EFO_0004612, EFO_0020947 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 1.31e-03 | 222 | 63 | 4 | EFO_0008317, EFO_0020943 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 1.36e-03 | 224 | 63 | 4 | EFO_0004530, EFO_0008317 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 1.41e-03 | 103 | 63 | 3 | EFO_0008595, EFO_0020944 | |
| Disease | atopic dermatitis (is_implicated_in) | 1.41e-03 | 26 | 63 | 2 | DOID:3310 (is_implicated_in) | |
| Disease | Depressive Symptoms | 1.41e-03 | 26 | 63 | 2 | C0086132 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.53e-03 | 106 | 63 | 3 | EFO_0008317, EFO_0008596 | |
| Disease | tuberculosis (is_implicated_in) | 1.64e-03 | 28 | 63 | 2 | DOID:399 (is_implicated_in) | |
| Disease | cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.70e-03 | 110 | 63 | 3 | EFO_0008317, EFO_0008596, EFO_0010351 | |
| Disease | free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.70e-03 | 110 | 63 | 3 | EFO_0008317, EFO_0008591, EFO_0008596 | |
| Disease | chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.70e-03 | 110 | 63 | 3 | EFO_0004574, EFO_0008317, EFO_0008596 | |
| Disease | prostate cancer (is_implicated_in) | 2.03e-03 | 117 | 63 | 3 | DOID:10283 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QDRLSNTLQTYIRCR | 356 | P11473 | |
| SRVVTQNICQYRSLQ | 746 | Q8N163 | |
| RVNVSVGYNCILNIT | 66 | Q8N3I7 | |
| SIEYVTQRNCNLTQI | 756 | P39086 | |
| DTIFLREYQTRQNQC | 76 | P19652 | |
| QALAACRTAQIVTQY | 211 | P48546 | |
| QRQRICVARALYQNT | 816 | O60706 | |
| LNSQVQQTIALRYAC | 641 | A6NHC0 | |
| FQLCTQTRQFYVSIQ | 951 | Q13367 | |
| GTNVTICYVSRNIQN | 161 | Q99650 | |
| VYNQQNEDTCIIRIS | 641 | Q9NZL6 | |
| INTQSIVQLVQRYRS | 1106 | O00763 | |
| LVNVRNCIRFYQTAE | 161 | Q9P2R3 | |
| NLNTIRTYQVCNVFE | 51 | P54762 | |
| TSVLSRQQVLLRYQQ | 96 | Q02252 | |
| VSCFVNFTRLQQITN | 41 | Q9NVX0 | |
| VSSQQFRRVFVQVLC | 346 | O43194 | |
| QGYILNSDQTTCRIQ | 266 | O00339 | |
| LSERKQITQRYCLQN | 486 | Q6DN12 | |
| ASRNQRILYTVLECQ | 66 | Q86U10 | |
| IRTYQVCNVFESSQN | 56 | P29323 | |
| VYLSQRNVASNQVCR | 686 | Q16549 | |
| ARVQTCINLITSQEY | 96 | Q9HBH9 | |
| IVCVSTQINYLNRAL | 226 | Q8N8Q9 | |
| RTYQVCNVRESSQNN | 76 | P54753 | |
| YQNTEEVCQLRTLVN | 676 | P50748 | |
| AETECRYATQLQQIQ | 351 | P19012 | |
| RIQQLQRRCQSYTLS | 461 | Q3MIN7 | |
| RVVVVTLNTSQYLCQ | 766 | P42694 | |
| RRAACTIQTAFRQYQ | 316 | Q9UPP2 | |
| LRYINITNCVTSSIN | 396 | Q7Z2Q7 | |
| YRITQTNNQLINCRN | 26 | A6NG13 | |
| RDTQISSRAVYQCNT | 396 | O94856 | |
| TVCLRREGQTVYQQV | 191 | Q9HCG7 | |
| QRYHQRTNTNVNCPI | 2446 | P02751 | |
| QAVARQDATLYCTQR | 896 | Q9P2H0 | |
| TTIEYVTQRNCNLTQ | 741 | Q13003 | |
| LYSFCQQSRRQRIIQ | 571 | P13807 | |
| RSRNAQVAVTQYQVL | 236 | Q96CM3 | |
| RARQQETQLCLYCSQ | 271 | Q6ZR62 | |
| QLVFCYTIIERNNRQ | 521 | Q9NYV6 | |
| YICQITTSLYRAQQI | 281 | Q9BX59 | |
| YQQVSQRAECRTSQL | 3766 | Q8WXH0 | |
| QVNRNTIYSTLVTCV | 381 | Q96ER9 | |
| GTYTCVVRRQQRVLT | 366 | O75900 | |
| QSQVQRYISCKSRFQ | 261 | Q8N695 | |
| ASRQVYICSNNIQAR | 161 | Q8NFT2 | |
| VQRRESIFCIQYNIR | 806 | P11055 | |
| QTQSRVITYAGCITQ | 86 | O14581 | |
| CVQYRLVVRDVNTLQ | 26 | Q9P2S5 | |
| IRINQDYIRTFCSQQ | 766 | Q8N5C6 | |
| TDYSVTRNNVIQLCL | 151 | Q8WXI2 | |
| EQERSTYVCNKRQQI | 451 | O95398 | |
| QQTRAQTACRLLSYL | 286 | Q8IU68 | |
| ILRQQIANELNYSCR | 956 | Q12768 | |
| TIYVCQESLQLREQQ | 391 | Q12800 | |
| QCYQLLRTATNVRVI | 321 | Q8IZM8 | |
| QRIQLQCQDGSTRTY | 141 | Q6X4U4 | |
| RRNNVTNYNTVVETN | 16 | P37275 | |
| CTIQLQSYRQEVDRT | 406 | O14863 | |
| SRQICYQSLQESVQV | 806 | Q96QU8 | |
| VLCRQVYANRSLTVQ | 701 | Q6ZMP0 | |
| NNRITYISNSDLQRC | 61 | O60603 | |
| RQQCVEYVTSILQSL | 1276 | Q69YN4 |